Person profile
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
REGENERON PHARMACEUTICALS, INC.
6 Jan 25
4
Denali Therapeutics Inc.
13 Nov 24
144
Denali Therapeutics Inc.
12 Nov 24
4
AGIOS PHARMACEUTICALS, INC.
24 Jun 24
4
AGIOS PHARMACEUTICALS, INC.
17 Jun 24
4
Prime Medicine, Inc.
14 Jun 24
4
Denali Therapeutics Inc.
4 Jun 24
4
AGIOS PHARMACEUTICALS, INC.
29 Feb 24
144
AGIOS PHARMACEUTICALS, INC.
27 Feb 24
4
AGIOS PHARMACEUTICALS, INC.
27 Feb 24
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | REGN Regeneron Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 448 |
2 Jan 25 | REGN Regeneron Pharmaceuticals | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
11 Nov 24 | DNLI Denali Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 32.87 | 32,312 | 1.06 mm | 9,220 |
11 Nov 24 | DNLI Denali Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 32.09 | 27,129 | 870.57 k | 41,532 |
11 Nov 24 | DNLI Denali Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 18 | 47,165 | 848.97 k | 68,661 |
11 Nov 24 | DNLI Denali Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 18 | 47,165 | 848.97 k | 0 |
20 Jun 24 | AGIO Agios Pharmaceuticals | Stock options Common stock | Grant | Acquire A | No | No | 42.45 | 11,774 | 499.81 k | 11,774 |
20 Jun 24 | AGIO Agios Pharmaceuticals | RSU Common stock | Grant | Acquire A | No | No | 0 | 2,120 | 0.00 | 2,120 |
13 Jun 24 | AGIO Agios Pharmaceuticals | Common stock | Option exercise | Acquire M | No | No | 0 | 3,388 | 0.00 | 126,242 |
13 Jun 24 | AGIO Agios Pharmaceuticals | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 3,388 | 0.00 | 0 |